ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ACAD Acadia Pharmaceuticals Inc

26.50
0.60 (2.32%)
Pre Market
Last Updated: 06:46:25
Delayed by 15 minutes

Period:

Draw Mode:

Volume 101
Bid Price 26.50
Ask Price 28.00
News -
Day High

Low
17.71

52 Week Range

High
33.99

Day Low
Company Name Stock Ticker Symbol Market Type
Acadia Pharmaceuticals Inc ACAD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.60 2.32% 26.50 06:46:25
Open Price Low Price High Price Close Price Prev Close
25.90
Trades Volume Avg Volume 52 Week Range
2 101 - 17.71 - 33.99
Last Trade Time Type Quantity Stock Price Currency
06:57:18 1 $ 26.50 USD

Acadia Pharmaceuticals (ACAD) Options Flow Summary

Overall Flow

Bullish

Net Premium

31k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Acadia Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.25B 164.18M - 517.24M -215.98M -1.32 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Acadia Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ACAD Message Board. Create One! See More Posts on ACAD Message Board See More Message Board Posts

Historical ACAD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week24.7725.9724.43525.091,198,6481.736.98%
1 Month27.8927.9423.5425.561,502,572-1.39-4.98%
3 Months22.6932.5920.7627.321,889,7263.8116.79%
6 Months28.5632.5920.30525.351,695,618-2.06-7.21%
1 Year19.1433.9917.7124.701,679,0197.3638.45%
3 Years49.3749.9112.2421.681,743,208-22.87-46.32%
5 Years23.0158.7212.2428.231,595,0213.4915.17%

Acadia Pharmaceuticals Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Your Recent History

Delayed Upgrade Clock